Avalo Therapeutics (AVTX) Operating Margin (QoQ) (2016 - 2024)
Powered by 
Analysis
Avalo Therapeutics (AVTX) Operating Margin (QoQ) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Avalo Therapeutics | 843.26 Mn | 843.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -176,775.00 |
| Dec 31, 2023 | 24,783.00 |
| Sep 30, 2023 | -47,701.00 |
| Jun 30, 2023 | 73,897.00 |
| Mar 31, 2023 | -86,267.00 |
| Dec 31, 2022 | -101,567.00 |
| Sep 30, 2022 | 117,241.00 |
| Jun 30, 2022 | 63,273.00 |
| Mar 31, 2022 | 642,453.00 |
| Dec 31, 2021 | -698,280.00 |
| Sep 30, 2021 | -70,893.00 |
| Jun 30, 2021 | 595,456.00 |
| Mar 31, 2021 | -537,367.00 |
| Dec 31, 2020 | 10,360.00 |
| Sep 30, 2020 | -31,202.00 |
| Jun 30, 2020 | 25,760.00 |
| Mar 31, 2020 | -15,531.00 |
| Dec 31, 2019 | -85,532.00 |
| Sep 30, 2019 | 5,201.00 |
| Jun 30, 2019 | 1,049.00 |